Philip Angelastro
Analyst · JP Morgan. Please go ahead
Thank you, John, and good morning. While, our business has continued to operate in the challenging marketplace, our agencies once again did well in meeting the financial and strategic goals we set for them. Total revenue for the third quarter was $3.7 billion with organic revenue growth of 2.8% that brings our year-to-date organic growth to 3.5%, due to a slightly weakening of the dollar against the currencies in our significant foreign markets. FX positively impacted our revenue by 1% in the third quarter. We also continue to experience of reduction relative to prior periods, and our reported revenues resulting from the disposition of several businesses that did not set our strategic priorities. This included Novus, our specialty print media business as well as certain agencies within our field marketing and events discipline. These dispositions net of our recent acquisitions reduced our third quarter revenue by $216 million or 5.7%. I'll go in to greater detail regarding the changes in our revenue in a few minutes. Looking at the income statement items below revenue, operating profit or EBIT for the quarter increased 2.4% to $464 million. With EBIT margin improving to 12.5%, a 50 basis point improvement versus Q3 of last year. Similarly, Q3 EBITDA increased to $492 million and the resulting EBITDA margin of 13.2% also represents a 50 basis point increase over Q3 2016. Main drivers of our margin improvement continued to be our ongoing efforts to improve cost efficiencies throughout the organization, which are focused on real estate, back office services, and procurement initiatives, as well as the positive impact on margins from the dispositions of several businesses late last year and early this year. For the balance of the year, we'll continue to expect that our dispositions will negatively impact our reported revenue and EBIT dollars. With the modest benefit of approximately 20 basis points to our overall EBIT margins. Now turning to the items below operating profit. Net interest expense for the quarter was $46.4 million, up $4.4 million versus Q3 last year, and up $1.1 million versus the second quarter of 2017, versus Q2 interest expense increased $2.2 million, primarily driven by reduction in the benefit from our fixed-to-floating interest rate swaps as well as an increase in interest rates. All interest income increased $1.1 million due to an increase in cash held by our international treasury centers relative to Q2, versus the third quarter of last year the increase in interest expense of $6.1 million was primarily driven by reduction in the benefit from our fixed-to-floating interest rate swaps as well as the increase in our commercial paper interest rates. This was partially offset by an increase in interest income of $1.7 million, while our cash balances held were down slightly versus last year, an increase in interest rates positively impacted income for the quarter. Turning to income tax expense, as you recall at the beginning of the year, we're required to adopt ASU 2016-09, which change the way income tax expenses recognized on share-based compensation under U.S. GAAP. Newly implemented standard requires that the difference between the book tax expense and the cash tax deduction recorded on our tax return from share-based compensation, we've recognized as income tax expense. This difference is generated as a result of our stock price on the date of the award compared to the stock price on either the date that restricted stock vests or the date that stock options are exercised. In the past on the GAAP is difference for us was recorded directly to equity and not to the P&L. The standard requires prospect of recognition and does not allow restatement of prior periods. As a result under the new standard, we recorded an additional tax benefit on share-based compensation of $4.8 million during the third quarter, which reduced our quarterly effective tax rate by 1.1% to 31.6%, and our year-to-date effective rate to 31.1%. Excluding the benefit from the adoption of the new accounting standard, our year-to-date effective tax rate would have been 32.6%, the same as the year-to-date rate for 2106, and in line with our expectations of 2017's full-year tax rate. Earnings from our affiliates were $1.1 million during the third quarter, down a little from $1.4 million in Q3 of 2016. And the allocation of earnings to the minority shareholders in our less than fully owned subsidiaries decreased slightly to $23.3 million. As a result of the foregoing items, our net income for the quarter increased by about $10 million or 3.9%, $263.6 million versus $253.8 million in Q3 of 2016. Now turning to the calculation of earnings per share for the third quarter on Slide 2. Net income available for common shareholders for the quarter was $263.3 million. Our net share repurchases made over the past year reduced our diluted share count by 2.5%, 232.7 million shares. As a result, our reported diluted EPS for the quarter was $1.13, up $0.07 or 6.6% versus diluted EPS of $1.06 from Q3 of last year. Q3 2017, the impact of the new income tax accounting standard increased our diluted EPS by about $0.02, because the final income tax benefit is based on Omnicom's share price at the future vesting date for restricted stock and at the exercise date for stock options. It is not possible to estimate with any degree of certainty the impact the new accounting pronouncement will have on our income tax rate, our net income, or our diluted EPS going forward. Please note that in future periods this impact could be positive or negative based on movements in our stock price. 2017 almost all of our share-based awards are restricted stock have vested for this year. As a result, the impact in the fourth quarter of the year is expected to be minor. On Slide 3 and 4, we provide the summary P&L, EPS, and other information for the year-to-date period. I will just give you few highlights, organic growth increased revenue by 3.5% during the first nine months of the year, while the FX headwind reduced revenue by 0.5% and the net impact of acquisitions and dispositions reduced revenue by $413 million or 3.7%. As a result, for the year-to-date period, revenue totaled $11.1 billion, a decrease of 0.7%, when compared to the first nine months of 2016. Operating profit or EBIT through nine months totaled $1.44 billion or EBITDA was $1.53 billion both increase in 2.3% versus last year. And our operating margins and EBITDA, an increased 40 basis points for the nine months compared to last year. And on Slide 4, you can see our year-to-date diluted EPS was $3.55 per share, which is up $0.24 or 7.3% versus 2016. Year-to-date the impact of the new accounting standard increased our diluted EPS by $0.08. Moving to the details of our revenue performance for the quarter, which starts on Slide 5. During the quarter for the first time since 2014, the net impact of the changes in currency rates had a positive impact on our revenue, adding 1% or $39 million. For financial reporting purposes major driver of our FX movement in the third quarter versus last year was the euro, which strengthened 5.7% against the dollar. In addition to the movement of the euro, the dollar weakened against the Australian dollar, and the Canadian dollar as well as several other currencies. The dollar also strengthened against the Japanese yen, British pound, and the Turkish lira. Over the past several quarters for financial reporting purposes, we experienced significant FX headwinds resulting from the decline of the British pound after the Brexit vote in June of 2016. We have now cycled through that significant year-over-year decline. If currencies stay where they currently are, based on our most recent projections, the net impact of FX is expected to be positive by approximately 2% in the fourth quarter, which would result in the impact of FX for the full year being flat. The impact of our recent acquisitions net of dispositions decreased revenue by $216 million in the quarter or 5.7%. As we have discussed, we completed several dispositions over the past 12 months, including the disposition this past April of Novus, our specialty print media business, which was located in the U.S and Canada. While we will continuously evaluate our portfolio of businesses, at this time we do not anticipate any additional significant dispositions during the remainder of 2017. Our current expectations are that the impact of acquisitions net of our disposition activity will reduce revenue by approximately 4.75% in the fourth quarter, and as a result by approximately 4% for the year. Organic growth was positive 2.8% or $106 million this quarter. Some highlights of our organic growth this quarter include geographically we had a solid performance in the UK and Continental Europe. And our North American agencies performed better in the quarter with growth of 2.1%. Our media offerings, including PHD and Hearts & Science, continue to perform very well, offset by some challenges faced by OMD. And Omnicom Healthcare Group had a solid performance at both its domestic and international agencies. On Slide 6, we present our regional mix of business. And you can see during the third quarter, the split was just under 57% for North America, about 10% for the UK, 18% for the rest of Europe, 11% for Asia Pacific, 3% for Latin America and 2% for Africa and the Middle East. Turning to the details of our performance by region on Slide 7, in North America, organic revenue growth was up 2.1%. While this was an improvement over recent quarters, the performance remains mixed across disciplines. We saw solid growth in our media, healthcare and events businesses, while our branding, direct marketing, point of sale and PR agencies underperformed. In the UK, organic growth was up 3.8%. While most of our businesses in the market continue their solid performance, overall organic growth was tempered by sluggish results from our field marketing and direct marketing businesses. The rest of Europe continues to perform well, up 7.8% organically in the quarter. All of the significant markets within Eurozone were positive organically, including strong performance in Germany France and Spain. We also saw solid performance by agencies in the smaller Euro markets, including Italy and Portugal. And The Netherlands had slightly positive organic growth in the quarter. Organic growth in Europe, outside the Eurozone was positive in most markets, except for Turkey, which had negative growth. The Asia-Pacific region was up 1.4%. Solid performances throughout the region, including in India, Japan and Singapore, were offset by some softness in China. Turning to Latin America, Brazil's economic issues continue to overshadow solid performances elsewhere in the region, with negative organic growth 5.4% in the quarter. While the comparison for Brazil Q3 of 2016 was inherently difficult due to an uptick in marketing activity last year as a result of the Rio Olympics, the ongoing macroeconomic issues continue to represent a significant challenge for our agencies there. Outside of Brazil, our agencies in Mexico and Colombia had strong performances. And finally, Africa and the Middle East, which was our smallest region was down 1.6%, largely due to decreases in project-based CRM businesses and a difficult comparison to last year. Slide 8 shows our mix of business by discipline. For the quarter, split was 52% for advertising services and 48% for marketing services. As for their organic growth performance, our advertising discipline was up 4.7%. Growth continues to be led by our media businesses, both domestically and internationally, and solid performances from certain of our full-service advertising agencies. CRM was up marginally for the quarter, with mixed results across our businesses and regions. Within CRM, our branding, direct marketing and point-of-sale businesses lagged, while our events businesses had a strong quarter. PR was slightly negative this quarter, driven mainly by weakness in the U.S. which saw a difficult comp due to the benefit last year of the presidential election. Specialty communications was up 5.1% organically, driven by the performance of our healthcare agencies here in the U.S. and across most international markets. Turning to Slide 9, we present our mix of revenue by our clients' industry sector. When comparing the year-to-date revenue for 2017 to 2016, you can see a slight shift in the percentages each industry contributed toward our total, with autos and food and beverage increasing, while the contribution from the consumer products and travel and entertainment industries decreasing. Turning to our cash flow performance, on Slide 10, you can see that in the first nine months of the year, we generated nearly $1.2 billion of free cash flow including changes in working capital. As for our primary uses of cash on Slide 11, dividends paid to our common shareholders were $388 million. The year-over-year change reflects the effects of the 10% increase in the quarterly dividend that was approved last year, partially offset by the reduction in shares outstanding due to repurchase activity. Dividends paid to our noncontrolling interest shareholders totaled $87 million. And capital expenditures were $108 million, up slightly this year. Acquisitions including earn-out payments, net of the proceeds received from the sale of investments totaled $87 million. And stock repurchases net of the proceeds received from stock issuances under our employee share plans totaled $514 million. All-in, we outspent our free cash flow by $13 million during the first nine months of the year. Turning to Slide 12, regarding our capital structure at the end of the quarter, our total debt at September 30 was $4.97 billion. Net debt at the end of September was just over $3.1 billion, in line with our prior year levels and an increase of about $1.2 billion since the beginning of the year, resulting from the use of working capital that normally occurs in the first nine months of the year, which was approximately $1.3 billion. This increase in net debt was partially offset by the effect of exchange rates on cash over the past nine months, which increased our cash balance by $196 million. As for our ratios, our total debt-to-EBITDA ratio was 2.1 times, and our net debt-to-EBITDA ratio was 1.3 times, and as a result of the year-over-year increase in our gross interest expense, our interest coverage ratio decreased 10.8 times, but still remains very strong. Turning to Slide 13, we continue to manage and build the company through a combination of internal development initiatives and reasonably priced acquisitions. In the last 12 months, our return on invested capital ratio moved to 20.2%, while our return on equity ratio was 48.9%, both increased from last year. And finally, on Slide 14, we track our cumulative return of cash to shareholders over the past 10 years. The line on the top of the chart, those are cumulative net income from the beginning of 2007 through September 30, 2017, which totaled $10.7 billion. While the bar shows the cumulative return of cash to shareholders, including both net share repurchases and dividends, which during the same period totaled $11.3 billion, all resulting in a cumulative payout ratio in excess of 100% since the beginning of 2007. And that concludes our prepared remarks. Please note that we have included a number of other supplemental slides in the presentation materials for your review. But at this point, we're going to ask the operator to open the call for questions. Thank you.